Genmab A/S (GNMSF)
290.00
0.00 (0.00%)
USD |
OTCM |
Mar 03, 16:00
Genmab EPS Diluted (Quarterly) : 0.4609 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ascendis Pharma A/S | -0.6364 |
| Zealand Pharma A/S | -0.8368 |
| Bavarian Nordic A/S | 0.7287 |
| ALK-Abello A/S | 0.1871 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 31.00M |
| Revenue (Quarterly) | 1.058B |
| Total Expenses (Quarterly) | 1.027B |
| Enterprise Value | 21.57B |
| Gross Profit Margin (Quarterly) | 92.34% |
| Profit Margin (Quarterly) | 2.93% |
| Earnings Yield | 5.32% |
| Operating Earnings Yield | 6.77% |
| Normalized Earnings Yield | 5.986 |